Melatonin as a potential inhibitory agent in head and neck cancer

Chia Ming Yeh, Shih Chi Su, Chiao Wen Lin, Wei En Yang, Ming Hsien Chien, Russel J. Reiter, Shun Fa Yang

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Melatonin is a molecule secreted by the pineal gland; it is an important regulator of sleep and circadian rhythms. Through multiple interrelated mechanisms, melatonin exhibits various inhibitory properties at different stages of tumor progression. Many studies have explored the oncostatic effects of melatonin on hormone-dependent tumors. In this review, we highlight recent advances in understanding the effects of melatonin on the development of head and neck cancers, including molecular mechanisms identified through experimental and clinical observations. Because melatonin exerts a wide range of effects, melatonin may influence many mechanisms that influence the development of cancer. These include cell proliferation, apoptosis, angiogenesis, extracellular matrix remodeling through matrix metalloproteinases, and genetic polymorphism. Thus, the evidence discussed in this article will serve as a basis for basic and clinical research to promote the use of melatonin for understanding and controlling the development of head and neck cancers.

Original languageEnglish
Pages (from-to)90545-90556
Number of pages12
JournalOncotarget
Volume8
Issue number52
DOIs
Publication statusPublished - 2017

Keywords

  • Head and neck cancers
  • Matrix metalloproteinase
  • Melatonin
  • Metastasis

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Melatonin as a potential inhibitory agent in head and neck cancer'. Together they form a unique fingerprint.

  • Cite this

    Yeh, C. M., Su, S. C., Lin, C. W., Yang, W. E., Chien, M. H., Reiter, R. J., & Yang, S. F. (2017). Melatonin as a potential inhibitory agent in head and neck cancer. Oncotarget, 8(52), 90545-90556. https://doi.org/10.18632/oncotarget.20079